bowness pharmacy limited

3

bowness pharmacy limited Company Information

Share BOWNESS PHARMACY LIMITED
Live 
EstablishedSmallDeclining

Company Number

06652821

Registered Address

16 daylesford road, cheadle, SK8 1LF

Industry

Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores

 

Dispensing chemist in specialised stores

 

Telephone

01616548534

Next Accounts Due

June 2024

Group Structure

View All

Directors

Lamya Dalal5 Years

Zulfikar Karimjee5 Years

View All

Shareholders

abk corporation limited 100%

bowness pharmacy limited Estimated Valuation

£293.2k - £1.3m

The estimated valuation range for bowness pharmacy limited, derived from financial data as of September 2022 and the most recent industry multiples, is between £293.2k to £1.3m

bowness pharmacy limited Estimated Valuation

£293.2k - £1.3m

The estimated valuation range for bowness pharmacy limited, derived from financial data as of September 2022 and the most recent industry multiples, is between £293.2k to £1.3m

bowness pharmacy limited Estimated Valuation

£293.2k - £1.3m

The estimated valuation range for bowness pharmacy limited, derived from financial data as of September 2022 and the most recent industry multiples, is between £293.2k to £1.3m

Get a detailed valuation report, edit figures and unlock valuation multiples.

Bowness Pharmacy Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Bowness Pharmacy Limited Overview

Bowness Pharmacy Limited is a live company located in cheadle, SK8 1LF with a Companies House number of 06652821. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in July 2008, it's largest shareholder is abk corporation limited with a 100% stake. Bowness Pharmacy Limited is a established, small sized company, Pomanda has estimated its turnover at £2.2m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Bowness Pharmacy Limited Health Check

Pomanda's financial health check has awarded Bowness Pharmacy Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3out of 5
positive_score

3 Strong

positive_score

3 Regular

positive_score

6 Weak

size

Size

annual sales of £2.2m, make it smaller than the average company (£10.9m)

£2.2m - Bowness Pharmacy Limited

£10.9m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -5%, show it is growing at a slower rate (4.9%)

-5% - Bowness Pharmacy Limited

4.9% - Industry AVG

production

Production

with a gross margin of 36.6%, this company has a comparable cost of product (36.6%)

36.6% - Bowness Pharmacy Limited

36.6% - Industry AVG

profitability

Profitability

an operating margin of 2.5% make it less profitable than the average company (5.2%)

2.5% - Bowness Pharmacy Limited

5.2% - Industry AVG

employees

Employees

with 20 employees, this is below the industry average (55)

20 - Bowness Pharmacy Limited

55 - Industry AVG

paystructure

Pay Structure

on an average salary of £35.3k, the company has an equivalent pay structure (£35.3k)

£35.3k - Bowness Pharmacy Limited

£35.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £110.8k, this is less efficient (£196.8k)

£110.8k - Bowness Pharmacy Limited

£196.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 31 days, this is earlier than average (43 days)

31 days - Bowness Pharmacy Limited

43 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 137 days, this is slower than average (52 days)

137 days - Bowness Pharmacy Limited

52 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 21 days, this is less than average (41 days)

21 days - Bowness Pharmacy Limited

41 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (19 weeks)

7 weeks - Bowness Pharmacy Limited

19 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 63.4%, this is a similar level of debt than the average (59%)

63.4% - Bowness Pharmacy Limited

59% - Industry AVG

bowness pharmacy limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for bowness pharmacy limited. Get real-time insights into bowness pharmacy limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Bowness Pharmacy Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for bowness pharmacy limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

bowness pharmacy limited Ownership

BOWNESS PHARMACY LIMITED group structure

Bowness Pharmacy Limited has no subsidiary companies.

Ultimate parent company

1 parent

BOWNESS PHARMACY LIMITED

06652821

BOWNESS PHARMACY LIMITED Shareholders

abk corporation limited 100%

bowness pharmacy limited directors

Bowness Pharmacy Limited currently has 4 directors. The longest serving directors include Mrs Lamya Dalal (May 2018) and Mr Zulfikar Karimjee (May 2018).

officercountryagestartendrole
Mrs Lamya DalalEngland32 years May 2018- Director
Mr Zulfikar KarimjeeEngland61 years May 2018- Director
Mr Alihussein DalalUnited Kingdom38 years May 2018- Director
Mr Shamoil KarimjeeEngland36 years Mar 2021- Director

BOWNESS PHARMACY LIMITED financials

EXPORTms excel logo

Bowness Pharmacy Limited's latest turnover from September 2022 is estimated at £2.2 million and the company has net assets of £558.7 thousand. According to their latest financial statements, Bowness Pharmacy Limited has 20 employees and maintains cash reserves of £118.4 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Sep 2022Sep 2021Sep 2020Sep 2019May 2018Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover2,215,8653,130,2102,605,8682,605,7332,255,8611,893,9251,279,2371,610,1691,271,5541,047,972737,771391,8400
Other Income Or Grants0000000000000
Cost Of Sales1,405,3912,086,2851,738,0011,718,4561,523,1161,201,501816,3371,027,398835,020693,585476,567251,0090
Gross Profit810,4741,043,925867,866887,277732,745692,423462,900582,771436,534354,387261,204140,8310
Admin Expenses755,214860,150764,493782,911571,218644,165426,605608,762432,391396,020246,59622,580-56,177
Operating Profit55,260183,775103,373104,366161,52748,25836,295-25,9914,143-41,63314,608118,25156,177
Interest Payable3,7673,1682,9402,4038098,22611,4227,07300000
Interest Receivable1,37192096374127509678609756589149
Pre-Tax Profit52,864180,616100,453102,059160,72134,87421,715-32,5554,821-41,02415,365118,84056,326
Tax-10,044-34,317-19,086-19,391-30,537-6,975-4,3430-1,1090-3,995-33,275-15,771
Profit After Tax42,820146,29981,36782,668130,18427,89917,372-32,5553,712-41,02411,37085,56540,555
Dividends Paid0000000000000
Retained Profit42,820146,29981,36782,668130,18427,89917,372-32,5553,712-41,02411,37085,56540,555
Employee Costs705,645740,031709,477692,777719,797271,649266,858334,475242,183217,935149,42886,9780
Number Of Employees20202020202191187530
EBITDA*83,921213,231117,661125,947169,56354,34341,458-20,14411,519-32,70022,159123,40460,829

* Earnings Before Interest, Tax, Depreciation and Amortisation

Sep 2022Sep 2021Sep 2020Sep 2019May 2018Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets383,032406,393257,548260,366126,60121,36021,94324,68029,41135,27730,43621,68622,625
Intangible Assets0000000000000
Investments & Other0000000000000
Debtors (Due After 1 year)00000191,824264,283246,34700000
Total Fixed Assets383,032406,393257,548260,366126,601213,184286,226271,02729,41135,27730,43621,68622,625
Stock & work in progress82,50081,25080,20082,50085,40984,39479,52378,17174,60565,79053,99928,68420,453
Trade Debtors188,617435,067357,069397,430321,152167,221190,050251,367178,005162,580133,53665,73453,541
Group Debtors689,127500,576359,062202,3650119,203105,908000000
Misc Debtors63,37562,68763,75859,14044,18625,92728,037000000
Cash118,3583,48214,97924,5591,08557,6821,54149,373154,241117,036126,629175,94359,693
misc current assets0000000000000
total current assets1,141,9771,083,062875,068765,994451,832454,427405,059378,911406,851345,406314,164270,361133,687
total assets1,525,0091,489,4551,132,6161,026,360578,433667,611691,285649,938436,262380,683344,600292,047156,312
Bank overdraft06,3106946,30924,88822,52238,212000000
Bank loan0000000000000
Trade Creditors 531,131507,382461,896511,284301,199310,114344,150358,738329,202276,16200110,006
Group/Directors Accounts35,0000000472972000000
other short term finances0000000000000
hp & lease commitments000001,4010000000
other current liabilities236,869253,609248,491177,97444,22141,67320,888000200,023160,3730
total current liabilities803,000767,301710,456735,567370,308376,182404,222358,738329,202276,162200,023160,373110,006
loans37,50047,50050,00000173,263196,679217,64100000
hp & lease commitments0000000000000
Accruals and Deferred Income0000000000000
other liabilities123,230156,19500000000000
provisions2,6292,6292,6292,6292,6294,2724,3894,9365,8827,0556,0874,5544,751
total long term liabilities163,359206,32452,6292,6292,629177,535201,068222,5775,8827,0556,0874,5544,751
total liabilities966,359973,625763,085738,196372,937553,717605,290581,315335,084283,217206,110164,927114,757
net assets558,650515,830369,531288,164205,496113,89485,99568,623101,17897,466138,490127,12041,555
total shareholders funds558,650515,830369,531288,164205,496113,89485,99568,623101,17897,466138,490127,12041,555
Sep 2022Sep 2021Sep 2020Sep 2019May 2018Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit55,260183,775103,373104,366161,52748,25836,295-25,9914,143-41,63314,608118,25156,177
Depreciation28,66129,45614,28821,5818,0366,0855,1635,8477,3768,9337,5515,1534,652
Amortisation0000000000000
Tax-10,044-34,317-19,086-19,391-30,537-6,975-4,3430-1,1090-3,995-33,275-15,771
Stock1,2501,050-2,300-2,90985,4094,8711,3523,5668,81511,79125,3158,23120,453
Debtors-57,211218,441120,954293,597365,338-84,10390,564319,70915,42529,04467,80212,19353,541
Creditors23,74945,486-49,388210,085301,199-34,036-14,58829,53653,040276,1620-110,006110,006
Accruals and Deferred Income-16,7405,11870,517133,75344,22120,78520,88800-200,02339,650160,3730
Deferred Taxes & Provisions00002,629-117-547-946-1,1739681,533-1974,751
Cash flow from operations136,84710,0271,050159,70636,328113,232-49,048-314,82938,0373,572-33,770119,87585,821
Investing Activities
capital expenditure-5,300-178,301-11,470-155,346-134,637-5,502-2,426-1,116-1,510-13,774-16,301-4,214-27,277
Change in Investments0000000000000
cash flow from investments-5,300-178,301-11,470-155,346-134,637-5,502-2,426-1,116-1,510-13,774-16,301-4,214-27,277
Financing Activities
Bank loans0000000000000
Group/Directors Accounts35,0000000-500972000000
Other Short Term Loans 0000000000000
Long term loans-10,000-2,50050,00000-23,416-20,962217,64100000
Hire Purchase and Lease Commitments000001,4010000000
other long term liabilities-32,965156,19500000000000
share issue000075,31200000001,000
interest-2,396-3,159-2,920-2,307-806-8,152-11,295-6,564678609756589149
cash flow from financing-10,361150,53647,080-2,30774,506-30,667-31,285211,0776786097565891,149
cash and cash equivalents
cash114,876-11,497-9,58023,4741,08556,141-47,832-104,86837,205-9,593-49,314116,25059,693
overdraft-6,3106,241-46,24021,42124,888-15,69038,212000000
change in cash121,186-17,73836,6602,053-23,80371,831-86,044-104,86837,205-9,593-49,314116,25059,693

P&L

September 2022

turnover

2.2m

-29%

operating profit

55.3k

0%

gross margin

36.6%

+9.67%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

September 2022

net assets

558.7k

+0.08%

total assets

1.5m

+0.02%

cash

118.4k

+32.99%

net assets

Total assets minus all liabilities

bowness pharmacy limited company details

company number

06652821

Type

Private limited with Share Capital

industry

47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores

47730 - Dispensing chemist in specialised stores

incorporation date

July 2008

age

16

accounts

Total Exemption Full

ultimate parent company

previous names

N/A

incorporated

UK

address

16 daylesford road, cheadle, SK8 1LF

last accounts submitted

September 2022

bowness pharmacy limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 5 charges/mortgages relating to bowness pharmacy limited. Currently there are 3 open charges and 2 have been satisfied in the past.

charges

bowness pharmacy limited Companies House Filings - See Documents

datedescriptionview/download